Antihypertensive Deprescribing and Functional Status in VA Long‐Term Care Residents With and Without Dementia
Journal of the American Geriatrics Society · 2025
DOI: 10.1111/jgs.19342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2025. Verfasst von Xiaojuan Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Deprescriptions, Antihypertensive Agents, Activities of Daily Living, Long-Term Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Deprescribing antihypertensives is of growing interest in geriatric medicine, yet the impact on functional status is unknown. We emulated a target trial of deprescribing antihypertensive medications compared with continued use on functional status measured by activities of daily living (ADL) in a long‐term care population.
Methods
We included 12,238 Veteran Affairs long‐term care residents age 65+ who had a stay ≥ 12 weeks between 2006 and 2019. After 4+ weeks of stable antihypertensive medication use, residents were classified as either deprescribed antihypertensives (reduced ≥ 1 medication or ≥ 30% dose) or continued users. Residents were followed up for 2 years, or censored at discharge, admission to hospice, protocol deviation (per‐protocol analysis only), or Sept 30, 2019. The outcome was ADL dependencies (scored 0–28; higher score = worse functionality), assessed approximately every 3 months. Our primary approach was to estimate per‐protocol effects using linear mixed‐effects regressions with inverse probability of treatment and censoring weighting, overall and stratified by dementia status. We estimated intention‐to‐treat effects as a secondary analysis.
Results
In long‐term care residents, ADL scores worsened by a mean of 0.29 points (95%CI = 0.27, 0.31) per 3 months and antihypertensive deprescribing did not impact this worsening (difference between groups −0.04 points every 3 months, 95%CI = −0.15, 0.06). In the non‐dementia subgroup, ADL worsened by 0.15 points (95%CI = 0.11, 0.19) every 3 months. However, residents who were deprescribed showed a slightly improved ADL score over time while the continued users showed ADL decline (difference between groups −0.23 points every 3 months, 95%CI = −0.43, −0.03). Deprescribing was not associated with ADL change in the dementia subgroup. The intention‐to‐treat results were not meaningfully different.
Conclusions
Antihypertensive deprescribing did not have a deleterious effect on functional status in long‐term care residents with or without dementia. This may be reassuring to residents and clinicians who are considering antihypertensive medication reduction or discontinuation in long‐term care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA.
- Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California, USA.
- Health Economics Resource Center, VA Palo Alto Health Care System, Palo Alto, California, USA.
- Stanford-Surgery Policy Improvement Research Education Center, Department of Surgery, Stanford University, Stanford, California, USA.
- Geriatrics, Palliative, and Extended Care Service Line, San Francisco VA Medical Center, San Francisco, California, USA.
- Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Michael A Steinman, Christine K Liu, Michelle C Odden
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- Health Services Research and Development
- National Institute on Aging
Zitieren
APA
Liu, X., Graham, L. A., Jing, B., Dave, C. V., Li, Y., Kurella Tamura, M., Steinman, M. A., Lee, S. J., Liu, C. K., Abdel Magid, H. S., Manja, V., Fung, K., & Odden, M. C. (2025). Antihypertensive Deprescribing and Functional Status in VA Long‐Term Care Residents With and Without Dementia. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.19342
Vancouver
Liu X, Graham LA, Jing B, Dave CV, Li Y, Kurella Tamura M, et al. Antihypertensive Deprescribing and Functional Status in VA Long‐Term Care Residents With and Without Dementia. Journal of the American Geriatrics Society. 2025. doi:10.1111/jgs.19342
BibTeX
@article{Liu2025,
author = {Liu, Xiaojuan and Graham, Laura A and Jing, Bocheng and Dave, Chintan V and Li, Yongmei and Kurella Tamura, Manjula and Steinman, Michael A and Lee, Sei J and Liu, Christine K and Abdel Magid, Hoda S and Manja, Veena and Fung, Kathy and Odden, Michelle C},
title = {Antihypertensive Deprescribing and Functional Status in VA Long‐Term Care Residents With and Without Dementia},
journal = {Journal of the American Geriatrics Society},
year = {2025},
doi = {10.1111/jgs.19342}
}
EUVIMED